This combination medication contains 2 reverse transcriptase inhibitors, prescribed for HIV infection in adults and pediatric patients 12 years of age and older.
♦It should not be used in individuals with unknown or positive HIV-1 status.
One tablet (containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate) once daily taken orally.
It comes as a tablet to take by mouth, with or without food.
• Caution should be exercised in patients with history of kidney problems, lactic acidosis, liver problems including HBV infection, osteoporosis, any allergy, who are taking other medications, during pregnancy and breastfeeding.
• It may cause dizziness or light-headedness, do not drive a car or operate machinery while taking this medication.
• It does not stop spread of HIV infection to others; avoid sexual contact, sharing of needles, injection supplies, or items like toothbrushes or razors during treatment period.
• Monitor liver function, kidney function, and bone mineral density regularly while taking this medication.
• Gastrointestinal :
Diarrhea, nausea, vomiting.
• General : Injection site reactions, fatigue.
• Infections : Sinusitis, upper respiratory tract infections, throat infection.
• Central Nervous System : Headache, dizziness, psychiatric disorders, depression, sleeplessness.
• Skin : Rash.
Avoid excess dosage.
Store the medication as directed by your physician.
Subscribe to our Free Newsletters!
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...View All